Chocolate or Sevoflurane: Use of Parosmia to Facilitate More Cooperative Inhalation Inductions in Children
Launched by JOHNS HOPKINS UNIVERSITY · Jun 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a technique called parosmia, which changes the way children perceive smells, can help make the experience of going under anesthesia less stressful. Many children feel anxious and scared during surgery, especially when they have to breathe in anesthetic gases like sevoflurane, which can have an unpleasant smell. The researchers hope that by using parosmia, they can create a more pleasant smell that encourages children to cooperate better during the induction of anesthesia. This is an important step toward improving children's overall experience in the operating room.
To participate in this study, children aged 5 to 12 years old who are generally healthy (classified as ASA I or II) may be eligible. However, children who need emergency surgery, cannot follow pre-surgery food and drink rules, or have certain medical conditions will not be included. Participants will be closely monitored to see if using parosmia helps reduce their anxiety during the process of getting anesthesia. This trial is currently recruiting, and while it is a small-scale study, the findings could lead to larger studies in the future to better understand how to support children during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages of 5-12 years old
- • American Society of Anesthesiologist physical status classification system (ASA) I and II
- • Patients coming from home
- Exclusion Criteria:
- • Patients undergoing emergent surgery
- • Patients who have not adequately maintained preoperative nothing per mouth/os (NPO) status
- • Patients with inability to communicate verbally
- • Tracheostomy patients
- • ASA III , IV, V patients
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Pooja O'Neil, MD
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported